Daniel from Improve Press
PocketHealth, a platform that permits sufferers to entry their medical imaging, introduced it secured $33 million in an all-equity Sequence B funding spherical led by Round13 Capital.
Deloitte Ventures participated within the spherical alongside Samsung Subsequent and present traders Radical Ventures and Questa Capital.
WHAT IT DOES
PocketHealth supplies an AI-enabled platform that permits sufferers to entry their medical imaging and different well being information, which they’ll then share with the supplier of their selection. Sufferers even have entry to MyCare Navigator, the place they’ll get solutions to health-related questions and preventive care suggestions.
Suppliers, in flip, can share photos with their sufferers and set personalised appointment reminders.
The corporate plans to make use of the brand new capital to increase its workforce over the approaching years and scale its choices throughout the U.S. and Canada.
“Medical imaging is the spark to just about each affected person journey, but handbook and legacy picture sharing techniques deemphasize affected person entry to their very own knowledge, producing pointless prices and delaying affected person care,” Rishi Nayyar, cofounder and CEO of PocketHealth, mentioned in an announcement.
THE LARGER TREND
PocketHealth secured $16 million in Sequence A funding in 2022. On the time, the corporate mentioned the funds would assist gas product innovation, increase its workforce and construct new partnerships.
Giving sufferers entry to their medical information has been proven to empower them to stick to therapy suggestions, particularly for sufferers with continual circumstances.
One other firm serving to sufferers entry their medical information is well being expertise firm PicnicHealth. In 2022, it scored $60 million in Sequence C funding, two years after touchdown $25 million in Sequence B funding.
PicnicHealth has additionally introduced a number of partnerships with pharma giants, together with AstraZenca and Roche and its subsidiary Genentech. The offers allowed the pharmaceutical firms to entry PicnicHealth’s set of de-identified affected person information to realize insights about sure ailments and coverings.
